Triamcinolone Acetonide Ointment
NDC Package 33342-331-80
Package Information
Triamcinolone Acetonide ointment is a medication used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). This formulation utilizes a ointment delivery system. Marketed by Macleods Pharmaceuticals Limited, this product is identified by NDC 33342-331 and is authorized under FDA application ANDA209828.
Identification & Billing
- RxCUI: 1085633 - triamcinolone acetonide 0.025 % Topical Ointment
- RxCUI: 1085633 - triamcinolone acetonide 0.00025 MG/MG Topical Ointment
- RxCUI: 1085636 - triamcinolone acetonide 0.1 % Topical Ointment
- RxCUI: 1085636 - triamcinolone acetonide 0.001 MG/MG Topical Ointment
- RxCUI: 1085640 - triamcinolone acetonide 0.5 % Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 33342 - Macleods Pharmaceuticals Limited
- 33342-331 - Triamcinolone Acetonide
- 33342-331-80 - 1 TUBE in 1 CARTON / 80 g in 1 TUBE
- 33342-331 - Triamcinolone Acetonide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (33342-331). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 33342-331-80 identifies a specific commercial package of 1 tube in 1 carton / 80 g in 1 tube of Triamcinolone Acetonide, a human prescription drug labeled by Macleods Pharmaceuticals Limited. This ointment is formulated for topical use and contains triamcinolone acetonide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Macleods Pharmaceuticals Limited on November 23, 2018. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Triamcinolone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium- to strong-potency corticosteroid. The potency depends on the strength and the form that you use. For details on the potency of your product, ask your pharmacist.
How is this Macleods Pharmaceuticals Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 33342033180. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 80 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.